Hyperbaric Oxygen Therapy (HBOT) is a treatment for cardiology patients with ACS and severe heart attack, bypass patients, and even sternal infections after CABG.
The use of high-dose oxygen therapy to precondition patients before surgery can improve physiological function and reduce the need for intensive care. These benefits not only reduce the length of stay in the intensive care unit but also prevent complications and improve clinical outcomes.
How your patients will benefit from HBOT
- Enhances stem cell proliferation from the bone marrow and migration to the area of injury
- Decreases re-perfusion injury
- Decreases fibrosis
- May reduce the volume of heart muscle damaged after ACS
- Stimulates angiogenesis and potentially collateralization of blood flow
- Improve mitochondrial efficiency
- Profoundly decreases inflammation